Artiva Biotherapeutics (ARTV) Stock Chart & Stock Price History $2.05 +0.09 (+4.59%) As of 06/12/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Artiva Biotherapeutics Stock Price Performance The Artiva Biotherapeutics (ARTV) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 79.66%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Artiva Biotherapeutics traded at $2.05 with a market cap of $49.94 million and volume of 124,989 shares. Receive ARTV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.38%1 Month Performance0.00%3 Month Performance-63.39%Year-To-Date Performance-79.66% ARTV Stock Chart for Friday, June, 13, 2025 ARTV Chart by TradingView Artiva Biotherapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$1.96$2.05+4.59%$2.15$1.89124,989 shs$49.94 million06/11/2025$2.08$1.96-5.77%$2.14$1.96174,759 shs$47.75 million06/10/2025$2.11$2.08-1.42%$2.19$2.03143,008 shs$50.68 million06/09/2025$2.10$2.11+0.48%$2.15$2.0757,484 shs$51.41 million06/06/2025$1.96$2.10+7.14%$2.14$1.96212,193 shs$51.16 million06/05/2025$1.97$1.96-0.51%$2.00$1.9181,714 shs$47.75 million06/04/2025$1.95$1.97+1.03%$1.99$1.9174,451 shs$48.00 million06/03/2025$1.94$1.95+0.52%$1.99$1.89121,802 shs$47.51 million06/02/2025$1.96$1.94-1.02%$1.99$1.84151,043 shs$47.26 million05/30/2025$2.05$1.96-4.39%$2.04$1.8865,522 shs$47.75 million Get the Latest News and Ratings for ARTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$1.92$2.05+6.77%$2.06$1.87178,464 shs$49.94 million05/28/2025$1.97$1.92-2.54%$1.98$1.9064,201 shs$46.78 million05/27/2025$1.95$1.97+1.03%$2.03$1.9690,776 shs$48.00 million05/26/2025$1.95$1.95$2.08$1.9174,226 shs$47.51 million05/23/2025$1.98$1.95-1.52%$2.08$1.9174,226 shs$47.51 million05/22/2025$2.00$1.98-1.00%$2.06$1.88131,495 shs$48.24 million05/21/2025$2.16$2.00-7.41%$2.15$1.9970,015 shs$48.73 million05/20/2025$2.02$2.16+6.93%$2.16$1.9996,136 shs$52.62 million05/19/2025$2.03$2.02-0.49%$2.14$1.9494,513 shs$49.21 million05/16/2025$2.13$2.03-4.69%$2.17$2.02168,580 shs$49.46 million05/15/2025$1.81$2.13+17.68%$2.22$1.80245,081 shs$51.89 million05/14/2025$2.05$1.81-11.71%$2.10$1.80165,594 shs$44.10 million05/13/2025$2.10$2.05-2.38%$2.15$2.0395,549 shs$49.94 million05/12/2025$2.08$2.10+0.96%$2.23$2.06152,266 shs$51.16 million Related Companies NLTX Stock Price Chart TVGN Stock Price Chart DRUG Stock Price Chart IPHA Stock Price Chart CYBN Stock Price Chart PRQR Stock Price Chart LYEL Stock Price Chart VYGR Stock Price Chart NVCT Stock Price Chart OGI Stock Price Chart Receive ARTV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARTV) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artiva Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artiva Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARTV Stock Free ARTV Stock Alerts